TY  - JOUR
T1  - GAbapentin for postherpetic neuralgia—reply
AU  - Rowbotham MC, Magnus-Miller L, Bernstein P
Y1  - 1999/07/14
N1  - 10-1001/pubs.JAMA-ISSN-0098-7484-282-2-jbk0714
JO  - JAMA
SP  - 134
EP  - 135
VL  - 282
IS  - 2
N2  - 
Aside from the reason for presenting certain data, all AE data, irrespective
of investigator-rated causality, were collected in our study. Therefore, we
can provide the following information. While no serious AEs determined by
the investigator to be related to gabapentin were reported, 10 patients (9%)
in the gabapentin group reported a total of 17 serious AEs and 5 patients
(4%) in the placebo group reported a total of 5 serious AEs (
P=.19). For the gabapentin treatment group, the serious AEs consisted
of 1 case each of congestive heart failure, cellulitis, myocardial infarction,
cerebrovascular accident, unintentional injury, intestinal obstruction, cholecystitis,
peritonsillar abscess, and 2 cases each of pneumonia, nausea, vomiting, and
cholelithiasis (1 case accompanied by elevated γ-glutamyltransferase
and alkaline phosphatase levels). The group that received placebo reported
1 case each of unintentional injury, syncope, carcinoma of the lung, exacerbation
of depression, and cerebrovascular accident.

SN  - 0098-7484
M3  - doi: 10-1001/pubs.JAMA-ISSN-0098-7484-282-2-jbk0714
UR  - http://dx.doi.org/10-1001/pubs.JAMA-ISSN-0098-7484-282-2-jbk0714
ER  -